AP NEWS

Minimally Invasive Glaucoma Surgery (MIGS) Devices: Asia-Pacific Market Outlook to 2024, Expected to Grow at a CAGR of 31.8% - ResearchAndMarkets.com

November 23, 2018

DUBLIN--(BUSINESS WIRE)--Nov 23, 2018--The “Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering.

The Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is expected to witness market growth of 31.8% CAGR during the forecast period (2018-2024).

MIGS devices is expected to be most preferred surgical modality during the forecast period to treat glaucoma. It limits the dependency on conventional medications as well as cuts the complications associated with traditional procedures. Glaucoma is a progressive disease and is the major cause of irreversible blindness with an estimated burden to rise 111.8 million by 2040. This has increased the demand for MIGS devices in the treatment of glaucoma.

The factors driving the market include rapid rise in geriatric population, who are more prone to ophthalmology diseases such as glaucoma and cataract. The novel paradigm of glaucoma therapy by using MIGS devices will aspire to a much reduced dependence on topical medication. In addition, increasing preference of surgeons for MIGS is adding boost to the market growth.

Segments Covered

On the basis of Surgery, the market is segmented into Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma. Target is categorized into Trabecular Meshwork, Suprachoroidal Space and Other Targets. On the basis of Product, the market is segmented into MIGS Stents, MIGS Shunts and Other Products. The End Users covered under the report are Eye Hospitals, Ophthalmology Clinics and Others. Based on Countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Key Topics Covered

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery

Chapter 4. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target

Chapter 5. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product

Chapter 6. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User

Chapter 7. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country

Chapter 8. Company Profiles

Ellex Medical Lasers Ltd. Allergan PLC Santen Pharmaceutical Co. Ltd. Glaukos Corporation Alcon Inc. (Novartis) Lumenis Ivantis Inc. iSTAR Medical InnFocus Inc. SOLX Inc.

For more information about this report visit https://www.researchandmarkets.com/research/ftn4pt/_minimally?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181123005066/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical,Surgical Devices

KEYWORD: ASIA PACIFIC

INDUSTRY KEYWORD: SURGERY HEALTH OPTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/23/2018 05:30 AM/DISC: 11/23/2018 05:30 AM

http://www.businesswire.com/news/home/20181123005066/en

AP RADIO
Update hourly